Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dasatinib 39.5mg tablets
0801050ANAAAIAI
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 50mg tablets
0801050ANAAABAB
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 63.2mg tablets
0801050ANAAAJAJ
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 70mg tablets
0801050ANAAACAC
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 79mg tablets
0801050ANAAAKAK
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 80mg tablets
0801050ANAAAFAF
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Daunorubicin (liposomal) 50mg/25ml inf vials
0801020J0AAAAAA
|
Daunorubicin | Daunorubicin | Malignant Disease and Immunosuppression | No data available |
|
Daunorubicin 20mg powder for solution for infusion vials
0801020J0AAABAB
|
Daunorubicin | Daunorubicin | Malignant Disease and Immunosuppression | No data available |
|
DaunoXome 50mg/25ml concentrate for inf vials
0801020J0BBAAAA
|
DaunoXome | Daunorubicin | Malignant Disease and Immunosuppression | No data available |
|
Decitabine 50mg powder for solution for infusion vials
0801030AEAAAAAA
|
Decitabine | Decitabine | Malignant Disease and Immunosuppression | No data available |
|
DepoCyte 50mg/5ml suspension for injection vials
0801030D0BEAAAN
|
Depocyte | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Dexrazoxane 500mg powder for solution for infusion vials
0801000Y0AAAAAA
|
Dexrazoxane | Dexrazoxane | Malignant Disease and Immunosuppression | No data available |
|
Diethylstilbestrol 5mg tablets
0803010K0AAALAL
|
Diethylstilbestrol (Systemic) | Diethylstilbestrol | Malignant Disease and Immunosuppression | No data available |
|
Dimethyl fumarate 120mg gastro-resistant capsules
0802040AKAAAAAA
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | No data available |
|
Dimethyl fumarate 240mg gastro-resistant capsules
0802040AKAAABAB
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | No data available |
|
Disodium folinate 100mg/2ml solution for injection vials
0801000X0AAAAAA
|
Disodium folinate | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Disodium folinate 200mg/4ml solution for injection vials
0801000X0AAADAD
|
Disodium folinate | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Disodium folinate 400mg/8ml solution for injection vials
0801000X0AAABAB
|
Disodium folinate | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Disodium folinate 50mg/1ml solution for injection vials
0801000X0AAAEAE
|
Disodium folinate | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Disodium folinate 900mg/18ml solution for injection vials
0801000X0AAACAC
|
Disodium folinate | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 140mg/7ml solution for infusion vials
0801050D0AAAHAH
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 160mg/16ml solution for infusion vials
0801050D0AAAGAG
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 160mg/8ml solution for infusion vials
0801050D0AAAIAI
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/0.5ml solution for infusion vials and diluent
0801050D0AAAAAA
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/0.72ml inf vials and diluent
0801050D0AAALAL
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.